Analysis of tumor necrosis factor α‑induced and nuclear factor κB‑silenced LNCaP prostate cancer cells by RT‑qPCR

Gonen‑Korkmaz,Ceren; Sevin,Gulnur; Gokce,Goksel; Zuhuri Arun,Mehmet; Yıldırım,Gokce; Reel,Buket; Kaymak,Aysegul; Ogut,Deniz

doi:10.3892/etm.2014.2032

Analysis of tumor necrosis factor α‑induced and nuclear factor κB‑silenced LNCaP prostate cancer cells by RT‑qPCR

Authors:
- Ceren Gonen‑Korkmaz
- Gulnur Sevin
- Goksel Gokce
- Mehmet Zuhuri Arun
- Gokce Yıldırım
- Buket Reel
- Aysegul Kaymak
- Deniz Ogut
View Affiliations

Affiliations: Department of Pharmacology, Faculty of Pharmacy, Ege University, Izmir 35100, Turkey
Published online on: October 17, 2014 https://doi.org/10.3892/etm.2014.2032
Pages: 1695-1700

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Prostate cancer is the second leading cause of morbidity and mortality in males in the Western world. In the present study, LNCaP, which is an androgen receptor‑positive and androgen‑responsive prostate cancer cell line derived from lymph node metastasis, and DU145, which is an androgen receptor‑negative prostate cancer cell line derived from brain metastasis, were investigated. TNFα treatment decreased p105 and p50 expression and R1881 treatment slightly decreased p105 expression but increased p50 expression with or without TNFα induction. As an aggressive prostate cancer cell line, DU145 transfected with six transmembrane protein of prostate (STAMP)1 or STAMP2 was also exposed to TNFα. Western blotting indicated that transfection with either STAMP gene caused a significant increase in NFκB expression following TNFα induction. In addition, following the treatment of LNCaP cells with TNFα, reverse transcription quantitative polymerase chain reaction (RT‑qPCR) was performed with a panel of apoptosis‑related gene primers. The apoptosis‑related genes p53, p73, caspase 7 and caspase 9 showed statistically significant increases in expression levels while the expression levels of MDM2 and STAMP1 decreased following TNFα induction. Furthermore, LNCaP cells were transfected with a small interfering NFκB (siNFκB) construct for 1 and 4 days and induced with TNFα for the final 24 h. RT-qPCR amplifications were performed with apoptosis‑related gene primers, including p53, caspases and STAMPs. However, no changes in the level of STAMP2 were observed between cells in the presence or absence of TNFα induction or between those transfected or not transfected with siNFκB; however, the level of STAMP1 was significantly decreased by TNFα induction, and significantly increased with siNFκB transfection. Silencing of the survival gene NFκB caused anti‑apoptotic STAMP1 expression to increase, which repressed p53, together with MDM2. NFκB silencing had varying effects on a panel of cancer regulatory genes. Therefore, the effective inhibition of NFκB may be critical in providing a targeted pathway for prostate cancer prevention.

View Figures

View References

1	Lorenzo PI, Arnoldussen YJ and Saatcioglu F: Molecular mechanisms of apoptosis in prostate cancer. Crit Rev Oncog. 13:1–38. 2007. View Article : Google Scholar
2	Hubert RS, Vivanco I, Chen E, Rastegar S, Leong K, Mitchell SC, Madraswala R, et al: STEAP: a prostate-specific cell-surface antigen highly expressed in human prostate tumors. Proc Natl Acad Sci USA. 96:14523–14528. 1999. View Article : Google Scholar : PubMed/NCBI
3	Korkmaz KS, Elbi C, Korkmaz CG, Loda M, Hager GL and Saatcioglu F: Molecular cloning and characterization of STAMP1, a highly prostate-specific six transmembrane protein that is overexpressed in prostate cancer. J Biol Chem. 277:36689–36696. 2002. View Article : Google Scholar : PubMed/NCBI
4	Korkmaz CG, Korkmaz KS, Kurys P, Elbi C, Wang L, Klokk TI, Hammarstrom C, et al: Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer. Oncogene. 24:4934–4945. 2005. View Article : Google Scholar : PubMed/NCBI
5	Wellen KE, Fucho R, Gregor MF, Furuhashi M, Morgan C, Lindstad T, Vaillancourt E, et al: Coordinated regulation of nutrient and inflammatory responses by STAMP2 is essential for metabolic homeostasis. Cell. 129:537–548. 2007. View Article : Google Scholar : PubMed/NCBI
6	Steiner MS, Zhang X, Wang Y and Lu Y: Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. Cancer Res. 60:4419–4425. 2000.PubMed/NCBI
7	Passer BJ, Nancy-Portebois V, Amzallag N, Prieur S, Cans C, Roborel de Climens A, et al: The p53-inducible TSAP6 gene product regulates apoptosis and the cell cycle and interacts with Nix and the Myt1 kinase. Proc Natl Acad Sci USA. 100:2284–2289. 2003. View Article : Google Scholar : PubMed/NCBI
8	Wang L, Jin Y, Arnoldussen YJ, Jonson I, Qu S, Maelandsmo GM, Kristian A, et al: STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer. Cancer Res. 70:5818–5828. 2010. View Article : Google Scholar : PubMed/NCBI
9	Hussain SP and Harris CC: Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 121:2373–2380. 2007. View Article : Google Scholar : PubMed/NCBI
10	Morgan MJ and Liu Z: Crosstalk of reactive oxygen species and NF-κB signaling. Cell Res. 21:103–115. 2011.
11	Morgan MJ, Kim YS and Liu ZG: TNFalpha and reactive oxygen species in necrotic cell death. Cell Res. 18:343–349. 2008. View Article : Google Scholar : PubMed/NCBI
12	Jablonska E, Piotrowski L and Grabowska Z: Serum levels of IL-1β, IL-6, TNF-α, sTNFR1 and CRP in patients with oral cavity cancer. Pathol Oncol Res. 3:126–129. 1997.
13	Mukhopadhyay A, Bueso-Ramos C, Chatterjee D, Pantazis P and Aggarwal BB: Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines. Oncogene. 20:7597–7609. 2001. View Article : Google Scholar : PubMed/NCBI
14	Chen X, Kandasamy K and Srivastava RK: Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Cancer Res. 63:1059–1066. 2003.PubMed/NCBI
15	Galluzzi L, Morselli E, Kepp O, Tajeddine N and Kroemer G: Targeting p53 to mitochondria for cancer therapy. Cell Cycle. 7:1949–1955. 2008. View Article : Google Scholar : PubMed/NCBI
16	Vikhanskaya F, Toh WH, Dulloo I, Wu Q, Boominathan L, Ng HH, Vousden KH and Sabapathy K: p73 supports cellular growth through c-Jun-dependent AP-1 transactivation. Nat Cell Biol. 9:698–705. 2007. View Article : Google Scholar : PubMed/NCBI
17	Deeb D, Jiang H, Gao X, Al-Holou S, Danyluk AL, Dulchavsky SA and Gautam SC: Curcumin [1,7-bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione; C₂₁H₂₀O₆] sensitizes human prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L-induced apoptosis by suppressing nuclear factor-kappaB via inhibition of the prosurvival Akt signaling pathway. J Pharmacol Exp Ther. 321:616–625. 2007.
18	Wadgaonkar R and Collins T: Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression. J Biol Chem. 274:13760–13767. 1999. View Article : Google Scholar : PubMed/NCBI
19	Lamkanfi M and Kanneganti TD: Caspase-7: a protease involved in apoptosis and inflammation. Int J Biochem Cell Biol. 42:21–24. 2010. View Article : Google Scholar : PubMed/NCBI
20	Brentnall M, Rodriguez-Menocal L, Ladron De Guevara R, Cepero E and Boise LH: Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol. 14:322013. View Article : Google Scholar : PubMed/NCBI
21	Bharti AC and Aggarwal BB: Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol. 64:883–888. 2002. View Article : Google Scholar : PubMed/NCBI
22	Bharti AC and Aggarwal BB: Chemopreventive agents induce suppression of nuclear factor-kappaB leading to chemosensitization. Ann NY Acad Sci. 973:392–395. 2002. View Article : Google Scholar : PubMed/NCBI
23	Casanelles E, Gozzelino R, Marqués-Fernández F, Iglesias-Guimarais V, Garcia-Belinchón M, Sánchez-Osuna M, Solé C, et al: NF-κB activation fails to protect cells to TNFα-induced apoptosis in the absence of Bcl-xL, but not Mcl-1, Bcl-2 or Bcl-w. Biochim Biophys Acta. 1833:1085–1095. 2013.
24	Zhang L, Charron M, Wright WW, Chatterjee B, Song CS, Roy AK and Brown TR: Nuclear factor-kappaB activates transcription of the androgen receptor gene in Sertoli cells isolated from testes of adult rats. Endocrinology. 145:781–789. 2004. View Article : Google Scholar : PubMed/NCBI
25	Murillo H, Huang H, Schmidt LJ, Smith DI and Tindall DJ: Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology. 142:4795–4805. 2001. View Article : Google Scholar : PubMed/NCBI
26	Kikuchi E, Horiguchi Y, Nakashima J, Kuroda K, Oya M, Ohigashi T, Takahashi N, et al: Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice. Cancer Res. 63:107–110. 2003.PubMed/NCBI
27	Sun HZ, Yang TW, Zang WJ and Wu SF: Dehydroepiandrosterone-induced proliferation of prostatic epithelial cell is mediated by NFKB via PI3K/AKT signaling pathway. J Endocrinol. 204:311–318. 2010. View Article : Google Scholar : PubMed/NCBI